| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |